(Q45418234)

14 December 2017

Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in rats (English)

1 reference

14 December 2017

0 references

Jurgen Seppen

1

0 references

author name string

Conny Bakker

2

1 reference

14 December 2017

Berry de Jong

3

1 reference

14 December 2017

Cindy Kunne

4

1 reference

14 December 2017

Karin van den Oever

5

1 reference

14 December 2017

Kristin Vandenberghe

6

1 reference

14 December 2017

Rudi de Waart

7

1 reference

14 December 2017

Jaap Twisk

8

1 reference

14 December 2017

Piter Bosma

9

1 reference

14 December 2017

3 April 2006

1 reference

14 December 2017

1 reference

14 December 2017

13

1 reference

14 December 2017

6

1 reference

14 December 2017

1085-1092

1 reference

Human UDP-glucuronosyltransferases: metabolism, expression, and disease

14 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Diagnosis and management of Crigler-Najjar syndrome

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Mechanisms of bilirubin neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Nonviral gene transfer into liver and muscle for treatment of hyperbilirubinemia in the gunn rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Transplantation of Gunn rats with autologous fibroblasts expressing bilirubin UDP-glucuronosyltransferase: correction of genetic deficiency and tumor formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Long term correction of bilirubin-UDP-glucuronosyltransferase deficiency in Gunn rats by administration of a recombinant adenovirus during the neonatal period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Successful gene therapy of the Gunn rat by in vivo neonatal hepatic gene transfer using murine oncoretroviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Long-term reduction of serum bilirubin levels in Gunn rats by retroviral gene transfer in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Therapeutic lentivirus-mediated neonatal in vivo gene therapy in hyperbilirubinemic Gunn rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Adeno-associated virus vectors in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Immune response to lentiviral bilirubin UDP-glucuronosyltransferase gene transfer in fetal and neonatal rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Modified infusion procedures affect recombinant adeno-associated virus vector type 2 transduction in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

No evidence for tumorigenesis of AAV vectors in a large-scale study in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Long-term genetic modification of rhesus monkey hematopoietic cells following transplantation of adenoassociated virus vector-transduced CD34+ cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.01.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2006.01.014

1 reference

14 December 2017

1 reference